Most people shed infectious SARS-CoV-2 for about five to eight days after symptoms begin, even though PCR tests can stay positive for two weeks or longer. That gap between “still testing positive” and “still contagious” is the single most misunderstood aspect of COVID shedding, and it has real consequences for how long you actually need to worry about spreading the virus. The timeline shifts depending on your immune status, vaccination history, and whether you’re taking antivirals, but the core pattern is remarkably consistent across variants.
Detectable Virus and Infectious Virus Are Not the Same Thing
A PCR test picks up fragments of viral genetic material, and those fragments can linger in your nose and throat well after the virus itself has stopped being able to infect anyone. A systematic review of viral culture studies found that six of eight studies detected RNA for longer than 14 days, but the ability to grow live virus from patient samples dropped sharply after day eight from symptom onset.1PubMed Central. Viral cultures for COVID-19 infectious potential assessment – a systematic review For the Omicron variant specifically, the pooled duration of viable virus shedding was about five days, while PCR positivity lasted roughly 11 days on average.2PubMed Central. Duration of viable virus shedding and polymerase chain reaction positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract: a systematic review and meta-analysis
A study of cases in England during the first wave reinforced this pattern: viral load peaked around symptom onset, and the probability of culturing live virus dropped to about 6% by day 10. Interestingly, the pattern was similar in people who never developed symptoms and those who did.3PubMed Central. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 So a positive PCR result two weeks into your illness almost certainly means you’re carrying leftover RNA debris, not that you’re still a risk to the people around you.
The Contagious Window Starts Before You Feel Sick
One of COVID’s most effective tricks as a pathogen is its timing. Viral load peaks right around the moment symptoms appear, which means you’re most contagious in the day or two before you even know you’re infected. A study modeling transmission dynamics estimated that roughly 44% of secondary infections happened during the index case’s presymptomatic stage.4Nature Medicine. Temporal dynamics in viral shedding and transmissibility of COVID-19 That estimate comes from settings with active case-finding and household quarantine, so the proportion in everyday community spread could differ, but the basic point stands: by the time you feel a scratchy throat, you’ve likely already been spreading virus for a day or more.
After that peak, contagiousness drops fairly quickly. Modeling of the full infection course estimated it takes about four days from the start of viral shedding to reach peak viral load, with peak culture isolation probability around 75% at that point.5PubMed Central. Estimating infectiousness throughout SARS-CoV-2 infection course After the peak, the immune system begins clearing the virus and the infectious window narrows. A separate study found that mild symptoms generally started within a day of peak viral load, while moderate or severe symptoms tended to lag the peak by about two days, and that higher peak viral loads correlated with worse symptom severity.6PubMed Central. Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity
What a Rapid Antigen Test Actually Tells You
Rapid antigen tests have gotten a lot of criticism for being less sensitive than PCR, but that lower sensitivity turns out to be a feature when the question is “Am I contagious right now?” rather than “Do I have the virus?” The reason is that antigen tests detect viral protein, and they tend to light up most reliably when viral loads are high enough to contain infectious virus.
One study found that when the analysis was restricted to samples containing live, cultivable virus, antigen test sensitivity jumped to above 94%.7Journal of Clinical Virology. SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus Another study that initially seemed to show poor sensitivity found that 36 of the 39 patients “missed” by the antigen test had no viable virus at all. Once that was accounted for, sensitivity for detecting truly infectious cases reached about 98%, and the negative predictive value hit over 99%.8PubMed Central. Covid-19 antigen testing: better than we know? A test accuracy study
In practical terms, if you’re recovering from COVID and your rapid test has turned negative, the odds that you’re still carrying infectious virus are very low. A persistent positive rapid test, on the other hand, is a genuinely useful warning sign that you should still be careful around others. PCR, by contrast, tells you almost nothing about your current contagiousness in the later stages of illness because it is so sensitive that it catches residual fragments long after the danger has passed.
How Vaccination Changes the Shedding Timeline
Vaccination does not prevent infection, as anyone who’s been boosted and still caught COVID knows. But it does appear to shorten the period during which you shed infectious virus. A longitudinal study of Delta infections found that while vaccinated and unvaccinated people reached similar peak viral loads, vaccinated people cleared infectious virus faster. The median duration of detectable infectious virus dropped from about seven and a half days in unvaccinated participants to six days in vaccinated ones, and by days six through twelve, the odds of still shedding infectious virus were less than half as high for vaccinated people.9PubMed Central. Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study
The mechanism behind this makes intuitive sense. Vaccinated immune systems don’t necessarily block the virus from establishing itself, but they produce neutralizing antibodies faster once infection begins. Research has shown that the timing of antibody production matters more than the total amount produced: people who developed strong neutralizing activity within two weeks of symptom onset had lower peak viral loads and better outcomes than those whose antibody response was delayed.10Nature Medicine. Delayed production of neutralizing antibodies correlates with fatal COVID-19 Modeling work estimated that once neutralizing antibodies reach about 90% of their maximum level, which happens around 11 days after symptoms start, they reduce the half-life of both infected cells and circulating virus by roughly sixfold.11PubMed. Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis
Omicron Versus Delta and Other Variant Differences
You might expect different variants to behave very differently in terms of shedding, but the data is surprisingly mixed. A head-to-head comparison found that the duration of viable virus shedding was similar for Omicron and Delta infections, with a median time to negative viral culture of about six days in both groups.12PubMed Central. Duration of viable virus shedding in SARS-CoV-2 omicron variant infection Where the variants did differ was in peak infectious viral loads and incubation periods. Delta infections tended to produce higher peak infectious titers than Omicron BA.1, and Omicron had lower cell culture isolation probability at equivalent viral loads.13Nature Reviews Microbiology. SARS-CoV-2 viral load and shedding kinetics
The bigger shift across variants has been in how fast the whole infection cycle runs. A meta-analysis found that with each new major variant, the incubation period, serial interval, and generation time all got shorter. Omicron BA.1 had the shortest pooled incubation period at about three and a half days, and Omicron BA.5 had the shortest serial interval at around two and a half days.14PubMed Central. Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis Another analysis estimated a mean generation interval of about three days for Omicron compared to nearly four days for Delta.15PubMed Central. Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2 Shorter generation times mean the virus spreads faster through a population even if each individual’s shedding duration hasn’t changed much.
A combined analysis that adjusted for evolving population immunity found that age and the number of prior exposures to vaccination or infection also mattered. People who had been exposed at least five times through some combination of vaccination and infection tended to shed at lower peak levels.16PLOS Biology. Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants This lines up with what we know about vaccination: more immune priming means faster clearance.
Immunocompromised People Can Shed for Months
The timelines above apply to people with functioning immune systems. For people who are immunocompromised, such as organ transplant recipients, people on certain cancer treatments, or those with advanced HIV, the rules are different and the stakes are higher. A systematic review found that immunocompromised individuals can carry replication-competent virus in their respiratory tracts for months, sometimes while showing no symptoms at all.17PubMed Central. A Systematic Review of Prolonged SARS‐CoV‐2 Shedding in Immunocompromised Persons A case series described three deeply immunocompromised patients who shed infectious virus for several months, with one case involving a superinfection with a second strain of SARS-CoV-2 while still shedding the first.18PubMed Central. Long term SARS-CoV-2 infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection
This isn’t just a concern for the patients themselves. Prolonged replication inside an immunocompromised host gives the virus more opportunities to mutate, and some researchers believe this is one of the mechanisms by which new variants emerge. If you’re immunocompromised and have COVID, or if you’re caring for someone who is, standard isolation timelines are not designed with you in mind. Longer monitoring and culture-based testing, when available, give a much better picture of when the infectious period has actually ended.
Children, Severity, and What Actually Predicts Shedding Duration
A common early-pandemic worry was that children might be “silent spreaders,” shedding virus for longer despite having mild symptoms. The evidence doesn’t really support that. A German longitudinal study found that young children reached viral clearance by PCR at a median of about 20 days after infection, compared to 23 days for adults, with no statistically significant difference between the groups.19Frontiers in Pediatrics. SARS-CoV-2 viral clearance and viral load kinetics in young children (1–6 years) compared to adults: Results of a longitudinal study in Germany
What does seem to matter is disease severity. A study that stratified shedding dynamics by age, sex, and severity found that adults with severe COVID had higher viral loads at the start of illness than adults or children with mild disease. But once you controlled for severity, neither sex nor age predicted how long respiratory shedding lasted.20The Pediatric Infectious Disease Journal. Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data In other words, a child with moderate symptoms and an adult with moderate symptoms shed virus on roughly the same schedule. Severity is the better predictor, not age.
Fecal Shedding Outlasts Respiratory Shedding
Most discussions of COVID shedding focus on the respiratory tract, but the virus also shows up in stool, and it tends to hang around there longer. A systematic review pooling data from over 200 patients found that the median duration of fecal PCR positivity was 19 days, compared to 14 days for respiratory tract positivity. About 64% of patients who tested positive by both routes had longer-lasting fecal shedding.21Frontiers in Medicine. Incidence and Persistence of Viral Shedding in COVID-19 Post-acute Patients With Negativized Pharyngeal Swab: A Systematic Review In children, the difference was even more striking: one synthesis found that viral shedding through the gastrointestinal tract lasted an average of about 24 days from symptom onset, compared to about 11 days for respiratory shedding. In 89% of those cases, GI shedding persisted for up to four weeks after throat or nasal swabs had turned negative.20The Pediatric Infectious Disease Journal. Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data
Whether fecal shedding represents a meaningful transmission risk is less clear. Detection of viral RNA in stool doesn’t automatically mean the virus found there can infect someone. Most transmission appears to be respiratory. Still, the existence of prolonged GI shedding explains why COVID has been detectable in wastewater for community surveillance purposes long after case counts appeared to decline.
Paxlovid and the Rebound Problem
Nirmatrelvir-ritonavir (Paxlovid) was designed to reduce the risk of severe disease, and it does that. But it introduced a new wrinkle in the shedding conversation: viral rebound. Some people who take Paxlovid see their symptoms and viral levels improve during the five-day treatment course, only to have both return a few days after stopping the drug.
A prospective household study found that among participants eligible for antiviral treatment, about 32% of treated participants had virological rebound, compared to 24% of untreated participants. Among those at high risk for severe disease, treated participants were roughly three times more likely to experience culture-confirmed rebound than untreated participants.22The Lancet Infectious Diseases. SARS-CoV-2 infectious shedding and rebound among adults with and without oral antiviral use: two case-ascertained prospective household studies During rebound, researchers have found live infectious virus in patients’ nasal samples, meaning the rebound isn’t just a PCR blip; it represents a genuinely renewed contagious period. This matters because people who feel better after finishing Paxlovid naturally return to normal activities, only to become infectious again a day or two later.
Why Five Days of Isolation Became the Standard
The shift from 10-day to 5-day isolation guidelines in many countries was driven partly by data showing that most people clear infectious virus before day six, and partly by the economic reality that longer isolation was becoming unsustainable. But the fit between biology and policy isn’t perfect. A cost-effectiveness analysis used in modeling isolation strategies estimated that the probability of carrying viable virus was still around 70% on day six from the start of isolation.23PubMed Central. COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis That’s not trivial, and it’s why guidelines typically recommend adding a negative rapid test before ending isolation rather than simply counting days.
A study of healthcare workers returning after a five-day isolation found that the residual risk of transmission was low. The median time from symptom onset to negative viral culture in that group was four days, and contact tracing showed only a small number of potential transmission events linked to returning workers.24PubMed Central. Risk of transmission of COVID-19 from healthcare workers returning to work after a 5-day isolation, and kinetics of shedding of viable SARS-CoV-2 variant B.1.1.529 (Omicron) “Low risk” is not “no risk,” though. The safest approach remains testing out of isolation rather than simply timing out.
How COVID Shedding Compares to the Flu
Seasonal influenza remains the most natural comparison point for COVID’s shedding behavior. A rapid review comparing the two found that COVID’s infectious shedding window is meaningfully longer. By the end of day nine from symptom onset, all Omicron studies reported that at least 70% of participants had stopped shedding viable virus, and by the end of day 10, that threshold rose above 90%. For influenza, all studies hit the 90% resolution mark by the end of day nine, with some reaching it by day four.25PubMed Central. Risk period for transmission of SARS-CoV-2 and seasonal influenza: a rapid review The difference is only a day or two in absolute terms, but it compounds at the population level when millions of people are infected simultaneously.
Virus in the Air and on Surfaces
How long you shed virus from your body is only half the equation. How long that virus remains infectious once it leaves you depends on the environment. Laboratory work testing SARS-CoV-2 in aerosolized form found that the time needed for a 90% drop in infectious virus ranged from under five minutes at high temperature with direct simulated sunlight to over two hours under conditions mimicking an indoor or nighttime environment.26PubMed Central. The influence of temperature, humidity, and simulated sunlight on the infectivity of SARS-CoV-2 in aerosols Temperature and sunlight mattered more than humidity across the conditions tested.
This is why indoor gatherings in poorly ventilated spaces remain the highest-risk scenario for COVID transmission. Even if you’re on day four of symptoms and your viral load is dropping, aerosolized virus released into a stagnant indoor room can remain infectious for hours. Outdoor settings, sunny days, and good ventilation all dramatically shorten the survival time of the virus once it’s airborne. The practical takeaway is that your personal shedding timeline interacts with the physical environment: a mildly infectious person in a stuffy conference room can be a bigger transmission risk than a more infectious person at an outdoor barbecue.
Asymptomatic Shedding
People who never develop symptoms still shed virus on a similar trajectory to those who do. A study that cultured live virus from asymptomatic carriers found that the viral load threshold for successful culture was essentially the same as in symptomatic patients.27PubMed Central. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers The England study mentioned earlier also found that the probability of culturing virus from asymptomatic individuals was similar to that from symptomatic ones at comparable time points.3PubMed Central. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 The virus doesn’t need you to cough to spread; normal breathing and talking produce enough aerosol to transmit it when viral loads are high. The difference is that asymptomatic people are less likely to know they’re infected, which means they’re less likely to isolate and more likely to transmit. The biology is the same. The behavior is different, and that’s what makes asymptomatic spread so epidemiologically important.